EDRAMF
Edmond de Rothschild Asset Management (France) Portfolio holdings
AUM
$2.29B
This Quarter Return
-13.17%
1 Year Return
+15.68%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.03B
AUM Growth
+$3.03B
(-18%)
Cap. Flow
-$155M
Cap. Flow
% of AUM
-5.14%
Top 10 Holdings %
Top 10 Hldgs %
27.12%
Holding
240
New
29
Increased
60
Reduced
71
Closed
18
Top Buys
| 1 |
Chevron
CVX
|
$47.4M |
| 2 |
Quanta Services
PWR
|
$21.9M |
| 3 |
Micron Technology
MU
|
$19.6M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$12M |
| 5 |
ATI
ATI
|
$9.91M |
Top Sells
| 1 |
Owens Corning
OC
|
$30.2M |
| 2 |
D.R. Horton
DHI
|
$26.7M |
| 3 |
UBS Group
UBS
|
$21.1M |
| 4 |
RAD
Rite Aid Corporation
RAD
|
$20.6M |
| 5 |
Masco
MAS
|
$20.5M |
Sector Composition
| 1 | Financials | 23.28% |
| 2 | Healthcare | 20.61% |
| 3 | Technology | 14.87% |
| 4 | Industrials | 11.98% |
| 5 | Consumer Discretionary | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Quanta Services
PWR
$55.8B
| $21.9M | 0.72% |
+906,000
| New | +$21.9M |
|
52
ON Semiconductor
ON
$19.5B
| $21.8M | 0.72% |
2,316,400
+307,400
| +15% | +$2.89M |
|
53
Trane Technologies
TT
$90.9B
| $20.9M | 0.69% |
412,300
-173,720
| -30% | -$8.82M |
|
54
Johnson & Johnson
JNJ
$429B
| $20.8M | 0.69% |
222,400
-50,000
| -18% | -$4.67M |
|
55
Fluor
FLR
$6.93B
| $20.7M | 0.68% |
488,500
+25,000
| +5% | +$1.06M |
|
|
AGN
56
DELISTED
Allergan plc
AGN
| $20.4M | 0.67% |
75,100
+17,600
| +31% | +$4.78M |
|
57
Biogen
BIIB
$20.8B
| $18.7M | 0.62% |
64,180
+5,000
| +8% | +$1.46M |
|
|
AXLL
58
DELISTED
AXIALL CORP COM STK (DE)
AXLL
| $17.7M | 0.59% |
1,130,800
+310,700
| +38% | +$4.87M |
|
|
BGC
59
DELISTED
General Cable Corporation
BGC
| $16.1M | 0.53% |
1,350,000
+100,000
| +8% | +$1.19M |
|
60
Amgen
AMGN
$153B
| $15.4M | 0.51% |
111,100
+1,500
| +1% | +$207K |
|
|
S
61
DELISTED
Sprint Corporation
S
| $14.9M | 0.49% |
3,869,500
-2,150,000
| -36% | -$8.26M |
|
|
BHI
62
DELISTED
Baker Hughes
BHI
| $14.4M | 0.47% |
276,200
-1,900
| -0.7% | -$98.9K |
|
63
Thermo Fisher Scientific
TMO
$183B
| $14.3M | 0.47% |
117,000
| – | – |
|
64
Wells Fargo
WFC
$258B
| $13.8M | 0.46% |
269,270
| – | – |
|
|
65
Vertex Pharmaceuticals
VRTX
$102B
| $12M | 0.4% |
+115,000
| New | +$12M |
|
66
UnitedHealth
UNH
$279B
| $11.2M | 0.37% |
96,200
-2,300
| -2% | -$267K |
|
67
Perrigo
PRGO
$3.21B
| $11.1M | 0.37% |
70,500
+10,000
| +17% | +$1.57M |
|
68
MasTec
MTZ
$14.2B
| $11M | 0.36% |
691,900
+20,000
| +3% | +$317K |
|
69
Revvity
RVTY
$9.68B
| $10.6M | 0.35% |
230,100
-36,800
| -14% | -$1.69M |
|
70
Incyte
INCY
$17B
| $10.4M | 0.34% |
94,000
-28,500
| -23% | -$3.14M |
|
71
Centene
CNC
$14.8B
| $9.68M | 0.32% |
178,573
+13,773
| +8% | +$747K |
|
72
Ionis Pharmaceuticals
IONS
$9.64B
| $9.62M | 0.32% |
238,000
+37,300
| +19% | +$1.51M |
|
|
TTM
73
DELISTED
Tata Motors Limited
TTM
| $9.45M | 0.31% |
419,795
+52,709
| +14% | +$1.19M |
|
74
Regeneron Pharmaceuticals
REGN
$59.8B
| $9.3M | 0.31% |
20,000
| – | – |
|
75
General Motors
GM
$55B
| $9.1M | 0.3% |
303,200
| – | – |
|